Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from DXCM

Best Bang For Your Buck? 2 Bargain Stocks with 30%+ Upside

These two companies could present an opportunity for investors to gain access while they are relatively undervalued and before they appreciate once again.

How Is DexCom's Performance Compared to Other Medical Device Companies?

How Is DexCom's Performance Compared to Other Medical Device Companies?

DexCom has outperformed the broader medical devices industry over the past year, and analysts remain strongly bullish on the stock’s prospects.

DexCom, GE, SLB: Why Experts Rate These Stocks at Strong Buy

DexCom, GE, SLB: Why Experts Rate These Stocks at Strong Buy

Wall Street gives these three diverse names Strong Buy recommendations with high potential upside.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

What You Need to Know Ahead of DexCom’s Earnings Release

DexCom is all geared up to announce its second-quarter earnings towards the end of this month, and analysts anticipate a single-digit bottom-line growth.

2 ‘Strong Buy’ Stocks That the MAHA Movement AND Wall Street Love

Policies associated with the MAHA movement could boost these two stocks significantly.

DexCom Stock: Is DXCM Underperforming the Health Care Sector?

DexCom has underperformed the Health Care sector over the past year, but analysts are highly optimistic about the stock’s prospects.

What to Expect From DexCom's Next Quarterly Earnings Report

DexCom will release its first-quarter earnings next month, and analysts anticipate a single-digit bottom-line growth.

inkl

Read news from The Economist, FT, and more,
with one subscription

Is DexCom Stock Underperforming the Dow?

Is DexCom Stock Underperforming the Dow?

DexCom significantly underperformed the Dow over the past year, yet analysts remain strongly bullish on the stock’s long term prospects.

DexCom Stock Outlook: Is Wall Street Bullish or Bearish?

DexCom Stock Outlook: Is Wall Street Bullish or Bearish?

Although DexCom has significantly lagged behind the broader market over the past year, Wall Street analysts remain strongly optimistic about the stock's prospects.

What to Expect From DexCom's Q4 2024 Earnings Report

What to Expect From DexCom's Q4 2024 Earnings Report

DexCom is gearing up to release its fourth-quarter earnings next month, and analysts forecast single-digit profit growth.

Is DexCom Stock Underperforming the Nasdaq?

Is DexCom Stock Underperforming the Nasdaq?

Despite DexCom's lagging performance relative to the Nasdaq Composite over the past year, Wall Street analysts maintain a strong bullish outlook on the stock's prospects.

Are Wall Street Analysts Predicting DexCom Stock Will Climb or Sink?

Are Wall Street Analysts Predicting DexCom Stock Will Climb or Sink?

Despite DexCom’s underperformance relative to the broader market over the past year, Wall Street analysts remain bullish about the stock’s prospects.

Here's What to Expect From DexCom's Next Earnings Report

Here's What to Expect From DexCom's Next Earnings Report

DexCom is poised to announce its third-quarter results later this month, with analysts predicting a double-digit decline in the company's earnings.

Is DexCom Stock Underperforming the S&P 500?

Is DexCom Stock Underperforming the S&P 500?

Despite DexCom’s underperformance compared to the S&P 500 Index over the past year, Wall Street analysts are highly bullish about the stock’s prospects.

Get all your
news in one place.

100’s of premium titles.
One news app.

Is Wall Street Bullish or Bearish on DexCom Stock?

Despite DexCom lagging behind the broader market over the past year, Wall Street analysts remain bullish on the stock’s prospects.

Dexcom Stock Sinks on Sales Miss, Guidance Cut: What to Know

Dexcom stock is crashing Friday after the glucose monitoring company reported dismal Q2 revenue and slashed its full-year sales guidance. Here's what you need to know.

3 Top-Rated Healthcare Stocks With 20% to 35% Upside Potential

Amid a broader market rotation out of Big Tech stocks, investors can consider these three top-rated healthcare stocks with double-digit upside potential.

Earnings Preview: What to Expect From DexCom's Report

DexCom is gearing up to announce its second-quarter results this month, and analysts are anticipating a double-digit increase in the company’s bottom-line figure.

Get all your
news in one place.

100’s of premium titles.
One news app.

How Is DexCom's Stock Performance Compared to Other Medical Devices Stocks?

Despite DexCom’s underperformance compared to its industry, Wall Street analysts remain optimistic about the stock’s prospects.

3 Healthcare Stocks Benefiting From an Aging Population

The healthcare industry is poised for tremendous growth driven by the aging population and rising incidence of chronic diseases. Hence, quality healthcare stocks, Danaher (DHR), Amgen (AMGN), and DexCom (DXCM), benefiting from an aging population, might be worth looking into. Read more….

Investors Business Daily

S&P 500 Giants Lead Five Stocks Near Buy Points With Fed's Powell A Tailwind

S&P 500 stocks DexCom, Blackstone and Royal Caribbean lead five stocks around buy points after Fed chief Jerome Powell helped buoy markets.

Investors Business Daily

Five S&P 500 Stocks To Watch In Today's Market; Eli Lilly Reaches New High After Drug News

These S&P 500 stocks are industry leaders with good fundamentals and bullish charts. They may be right for your portfolio or your watchlist.

Investors Business Daily

Dexcom Surges 10% After Shrugging Off Weight-Loss Woes In Boosted Outlook

Dexcom topped third-quarter expectations, shrugging off concerns new weight-loss drugs would undercut its sales. DXCM stock popped Friday.

Investors Business Daily

Dow Jones Futures Rise After Market Reversal; Tesla Forges New Buy Point As Roku, Intel Jump Late

The Dow ended a 13-day streak as the Nasdaq led an ugly reversal. Tesla has a new buy point while Intel and Roku jumped late.

Investors Business Daily

Dexcom Earnings Tops Estimates, Medical Device Maker Hikes Outlook

Dexcom reported June-quarter earnings and revenue that topped Wall Street analyst targets and raised its full-year sales outlook.

People

Robert F. Kennedy Jr

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

Intel Corporation

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play